Submissions from 2023
FcγRIIB is an immune checkpoint limiting the activity of Treg-targeting antibodies in the tumor microenvironment., David A Knorr, Lucas Blanchard, Rom Leidner, Shawn M. Jensen, Ryan Meng, Andrew Jones, Carmen Ballesteros-Merino, Richard Bryan Bell, Maria Baez, Alessandra Marino, David Sprott, Carlo Bifulco, Brian D. Piening, Rony Dahan, Juan C Osorio, Bernard A Fox, and Jeffrey V Ravetch
Aortic Innovations and Cases, Ethan Korngold
It Isn’t Always That Easy: Challenging Access Strategies, Including Intravascular Lithotripsy, Ethan Korngold
Ultimate Balloon Valve Fracturing, Ethan Korngold
Transcatheter Aortic Valve Replacement Outcomes in End-Stage Renal Disease Patients on Hemodialysis Requiring Midodrine., Ethan C Korngold, Ruyun Jin, Kateri Spinelli, V Kumar, Brydan Curtis, Sameer Gafoor, Derek Phan, Daniel Spoon, Aidan Raney, Lisa McCabe, and Brandon Jones
Left Distal Radial Artery Access Site Pseudoaneurysm Treated with Open Surgical Repair, Ethan C Korngold, Daniel Westerdahl, and Brant Ullery
SALVO: Single Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma., Lisa A Kottschade, Gregory Russell Pond, Anthony J Olszanski, Yousef Zakharia, Evidio Domingo-Musibay, Ralph J Hauke, Brendan Curti, Sarah Schober, Mohammed M Milhem, Matthew S Block, Tina Hieken, and Robert R McWilliams
Fluorescence tracking demonstrates a rapid cycle of Treg recirculation to tumor draining lymph nodes and back to tumors that is interrupted by radiation therapy, G Kramer, Michael Gough, and See full list of authors in comments
The Effect of Preoperative Carbohydrate Intake on Length of Stay and Postoperative Recovery Following Laparoscopic Living Donor Nephrectomy., Morgan Kuiper, Melanie Gillingham, Julie Martin, Daniella Gardner, and Sandra Van Calcar
Logic Model and Data System Recommendations, Kristen Lacijan, Claire Devine, Natalie Royal Kenton, and Maggie Weller
Uterine Inflammatory Myofibroblastic Tumors: Proposed Risk Stratification Model Using Integrated Clinicopathologic and Molecular Analysis., Nicholas R Ladwig, Gregory R Bean, Melike Pekmezci, John Boscardin, Nancy M Joseph, Nicole Therrien, Ankur R Sangoi, Brian D. Piening, Venkatesh Rajamanickam, Matthew Galvin, Brady Bernard, Charles Zaloudek, Joseph T Rabban, Karuna Garg, and Sarah E Umetsu
Developing nurse leaders using implicit bias recognition education, Troy Larkin
Updates in Cardio-Oncology, ME Layoun
Regulation of human and mouse bystander T cell activation responses by PD-1., Catherine T Le, Logan V Vick, Craig Collins, Cordelia Dunai, Michael K Sheng, Lam T Khuat, Isabel Barao, Sean J Judge, Ethan G Aguilar, Brendan Curti, Maneesh Dave, Dan L Longo, Bruce R Blazar, Robert J Canter, Arta M Monjazeb, and William J Murphy
TCR engagers VS CAR-T, Rom Leidner
First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors., Rom Leidner, Kevin Conlon, Douglas G McNeel, Andrea Wang-Gillam, Sumati Gupta, Robert Wesolowski, Monica Chaudhari, Nadia Hassounah, Jong Bong Lee, Lang Ho Lee, Jessica A O'Keeffe, Nancy Lewis, George N Pavlakis, and John A Thompson
Amivantamab in Patients with Advanced NSCLC and MET Exon 14 Skipping Mutation: Results from the CHRYSALIS Study, N Leighl, Rachel Sanborn, and See all authors in comments
Phase 1/1b study of PRGN-3005 autologous UltraCAR-T cells manufactured overnight for infusion next day to advanced stage platinum resistant ovarian cancer patients, JB Liao, SE Stanton, and See all authors in comments
Evaluation of solid-phase panreactivity with negative direct antiglobulin testing., J T Little and D P Blackall
Trends and Factors Associated with Prophylactic Anticoagulation Strategies in COVID-19: an Analysis of the AHA COVID-19 CVD Registry, Mathew Lopes, Hsin-Fang Li, Reed Sorensen, Sandeep Das, Steven M. Bradley, James A. de Lemos, Gregory Andrew Roth, Tracy Wang, Erin Ann Bohula, and Tyler J Gluckman
An Analysis of Patient Characteristics Associated with Myelosuppression Among Small Cell Lung Cancer (SCLC) Patients Treated in US Community Cancer Care Practices, L Lopez-Gonzalez, Rachel E Sanborn, Roshanthi Weerasinghe, Amy S. Parrish, and See full list of authors in comments
SGN-B6A, an integrin beta-6 (ITGB6)-targeted antibody-drug conjugate (ADC), in patients with advanced solid tumors: Updated results from a phase 1 study (SGNB6A-001), JS Lopez, Rachel Sanborn, and See all authors in comments
Long-term efficacy, safety, and predictors of response to amivantamab among patients with post-platinum EGFR Ex20ins-mutated advanced NSCLC, PG Lopez, Rachel E Sanborn, and See full list of authors in comments
Long-term efficacy, safety, and predictors of response to amivantamab among patients with post-platinum EGFR Ex20ins-mutated advanced NSCLC, PG Lopez, RE Sanborn, and See full list of authors in comments
Feasibility of circulating tumor DNA (ctDNA) to guide organ preservation in patients with node-negative rectal cancer undergoing neoadjuvant chemotherapy, excision, and observation in the phase II CCTG CO.28 trial, Jonathan M. Loree, Hagen F Kennecke, and See full list of authors in comments
Poster Presented at the International Stroke Conference, T Lowenkopf, Alyx Lesko, and See all authors in comments
Lorigerlimab, a bispecific PD-1×CTLA-4 DART molecule in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): A phase 1 expansion (exp) cohort., Jason J. Luke, Rachel E Sanborn, and See full list of authors in comments
CT251 / 14 - Phase 1/2 study of HST-1011, an oral CBL-B inhibitor, alone and in combination with anti-PD1 in patients with advanced solid tumors, J Luke, Rachel E Sanborn, and See full list of authors in comments
Obesity Modifies Clinical Outcomes of Right Ventricular Dysfunction., Janet I Ma, Emily K Zern, Juhi K Parekh, Ndidi Owunna, Nona Jiang, Dongyu Wang, Paula K Rambarat, Eugene Pomerantsev, Michael H Picard, and Jennifer E Ho
Plasma phosphocreatine (PC) as a predictive biomarker for immune checkpoint inhibition in patients with refractory metastatic colorectal cancer (mCRC): Analysis of the CCTG CO.26 trial., Lucy Xiaolu Ma, Hagen F Kennecke, and See full list of authors in comments
Plasma arginine as a candidate predictive biomarker for response to immune checkpoint inhibition (ICI) in metastatic colorectal cancer (mCRC): Analysis of the CCTG CO.26 trial, LX Ma, H Kennecke, and See all authors in comments
Hyper-Dependence on NHEJ Enables Synergy Between DNA-PK Inhibitors and Low-Dose Doxorubicin in Leiomyosarcoma., Adrián Mariño-Enríquez, Jan Philipp Novotny, Doga C Gulhan, Isabella Klooster, Antuan V Tran, Macy Kasbo, Meijun Z Lundberg, Wen-Bin Ou, Derrick L Tao, Daniel F Pilco-Janeta, Victor Y Mao, Frank T Zenke, Brittaney A Leeper, Prafulla C Gokhale, Glenn S Cowley, Laurence H Baker, Karla V Ballman, David E Root, Joachim Albers, Peter J Park, Suzanne George, and Jonathan A Fletcher
Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of T, Mario L Marques-Piubelli, Riyad N H Seervai, Kumaran M Mudaliar, Wencai Ma, Denái R Milton, Jing Wang, Aaron Muhlbauer, Edwin R Parra, Luisa M Solis, Priyadharsini Nagarajan, Jodi Speiser, Courtney Hudgens, Woo Cheal Cho, Phyu P Aung, Anisha Patel, Omar Pacha, Kelly C Nelson, Michael T Tetzlaff, Rodabe N Amaria, Carlos A Torres-Cabala, Victor G Prieto, Ignacio I Wistuba, and Jonathan L Curry
Pure-ly for Authors: An Update of a Health System Researcher Profile Platform, Heather J. Martin and Amanda Schwartz
Learning from Each Other: Results from the first year of a peer-reviewed literature searching project, Heather Martin, Danielle Linden, and Carrie Grinstead
Leveling up Researcher Profiles: Changing Platforms, Changing Practice, Heather Martin and Amanda Schwartz
Neoadjuvant HER2-targeted Therapy +/- Immunotherapy with Pembrolizumab (neoHIP): An Open Label Randomized Phase II Trial, H McArthur, David B. Page, and See all authors in comments
A Single Arm Phase 2 Study of Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Hormone Receptor-Negative, HER2-Negative Early Stage/Resectable Breast Cancer, H McArthur, David Page, and See full list of authors in comments
Neoadjuvant HER2-targeted Therapy +/- Immunotherapy with Pembrolizumab (neoHIP): An Open Label Randomized Phase II Trial, H McArthur, David Page, and See full list of authors in comments
Guidelines for Diagnosis and Management of Infective Endocarditis in Adults: A WikiGuidelines Group Consensus Statement., Emily G McDonald, Gloria Aggrey, Abdullah Tarik Aslan, Michael Casias, Nicolas Cortes-Penfield, Mei Qin Denise Dong, Susan Egbert, Brent Footer, Burcu Isler, Madeline King, Mira Maximos, Terence C Wuerz, Ahmed Abdul Azim, Jhongert Alza-Arcila, Anthony D Bai, Michelle Blyth, Tom Boyles, Juan Caceres, Devin Clark, Kusha Davar, Justin T Denholm, Graeme Forrest, Bassam Ghanem, Stefan Hagel, Alexandra Hanretty, Fergus Hamilton, Philipp Jent, Minji Kang, Geena Kludjian, Tim Lahey, Jonathan Lapin, Rachael Lee, Timothy Li, Dhara Mehta, Jessica Moore, Clayton Mowrer, Georges Ouellet, Rebecca Reece, Jonathan H Ryder, Alexandre Sanctuaire, James M Sanders, Bobbi Jo Stoner, Jessica M So, Jean-François Tessier, Raghavendra Tirupathi, Steven Y C Tong, Noah Wald-Dickler, Arsheena Yassin, Christina Yen, Brad Spellberg, and Todd C Lee
Diaphragmatic relaxing incisions for complex hiatal reconstruction: longer-term follow-up confirms safety, efficacy and rare complications., Sarah C McKay, Steven R DeMeester, Ahmed Sharata, Melissa L DeSouza, Daniel Davila Bradley, Kevin M Reavis, and Christy M Dunst
Missed Opportunities: the Timing and Frequency of Screening Colonoscopy in Patients That Develop Esophageal Adenocarcinoma., Sarah C McKay, Melissa L DeSouza, Christy M Dunst, Kevin M Reavis, Daniel Davila Bradley, and Steven R DeMeester
Missed Opportunities: the Timing and Frequency of Screening Colonoscopy in Patients That Develop Esophageal Adenocarcinoma., Sarah C McKay, Melissa L DeSouza, Christy M Dunst, Kevin M Reavis, Daniel Davila Bradley, and Steven R DeMeester
Myeloid MyD88 restricts CD8+ T cell response to radiation therapy in pancreatic cancer, Terry R Medler, Tiffany Blair, Alejandro F Alice, Alexa K Dowdell, Brian D. Piening, Marka R Crittenden, and Michael J. Gough
Myeloid MyD88 restricts CD8, Terry R Medler, Tiffany C Blair, Alejandro F Alice, Alexa K Dowdell, Brian D Piening, Marka R Crittenden, and Michael J Gough
Tumor resident memory CD8 T cells and concomitant tumor immunity develop independently of CD4 help., Terry R Medler, Gwen Kramer, Shelly Bambina, Andrew J Gunderson, Alejandro Alice, Tiffany Blair, Lauren Zebertavage, Thomas Duhen, Rebekka Duhen, Kristina Young, Marka R Crittenden, and Michael J Gough
Muscle mass cross-sectional area is associated with survival outcomes in malignant pleural disease related to lung cancer., Austin M Meggyesy, Candice L. Wilshire, Shu-Ching Chang, Jed A Gorden, and Christopher R Gilbert
Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial., Mandeep R Mehra, Ivan Netuka, Nir Uriel, Jason N Katz, Francis D Pagani, Ulrich P Jorde, Finn Gustafsson, Jean M Connors, Peter Ivak, Jennifer Cowger, John Ransom, Aditya Bansal, Koji Takeda, Richa Agarwal, Mirnela Byku, Michael M Givertz, Abbas Bitar, Shelley Hall, Daniel Zimpfer, J David Vega, Manreet K Kanwar, Omar Saeed, Daniel J Goldstein, Rebecca Cogswell, Farooq H Sheikh, Matthew Danter, Yuriy Pya, Anita Phancao, John Henderson, Daniel L Crandall, Kartik Sundareswaran, Edward Soltesz, Jerry D Estep, ARIES-HM3 Investigators, and Jacob Abraham (ARIES-HM3 Investigators)
Multicenter Flow Diversion for Intracranial Aneurysms: Intracranial Hemorrhage & Thromboembolic Complications In A Multi-Center Cohort of 200 Patients, R Meister, Alyx Lesko, and See all authors in comments
Multicenter Flow Diversion in 200 individuals for treatment of intracranial aneurysms, R Meister, Alyx Lesko, and See all authors in comments
Enhancing Critical Appraisal of Literature through a Virtual Nursing Journal Club, Sherri Mendelson and Kevin Brandini
Characterizing cancer’s dark matter, short-lived proteins, and defective ribosomal products, presented by cancer and contained in the DPV-001 cancer vaccine, R Meng, Will Redmond, Carlo Bifulco, Rachel Sanborn, RB Bell, Walter Urba, Rom Leidner, Brian Piening, Bernard Fox, and See full list of authors in comments
Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With, Funda Meric-Bernstam, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Rodolfo Gutierrez, Eugene R Ahn, Timothy L Cannon, Steven Powell, John C Krauss, Christopher M Reynolds, Margaret von Mehren, Deepti Behl, Carmen J Calfa, Herbert L Duvivier, Henry G Kaplan, Michael B Livingston, Manish R Sharma, Walter Urba, Gina N Grantham, Dominique C Hinshaw, Abigail Gregory, Susan Halabi, and Richard L Schilsky
Abstract CT226: Crizotinib (C) in patients (pts) with solid tumors with MET amplification (amp) or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study, Kathryn F. Mileham, Rom Leidner, and See full list of authors in comments
Simultaneous identification of KRAS mutation-carrying multiple neoepitopes by differential ion mobility-assisted targeted-mass spectrometry, Y Minegishi, Eric Tran, Will Redmond, Brian Piening, Bernard Fox, and See all authors in comments
Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer., Bernhard Mlecnik, Alessandro Lugli, Gabriela Bindea, Florence Marliot, Carlo Bifulco, Jiun-Kae Jack Lee, Inti Zlobec, Tilman T Rau, Martin D Berger, Iris D Nagtegaal, Elisa Vink-Börger, Arndt Hartmann, Carol I Geppert, Julie Kolwelter, Susanne Merkel, Robert Grützmann, Marc Van den Eynde, Anne Jouret-Mourin, Alex Kartheuser, Daniel Léonard, Christophe Remue, Julia Wang, Prashant Bavi, Michael H A Roehrl, Pamela S Ohashi, Linh T Nguyen, SeongJun Han, Heather L MacGregor, Sara Hafezi-Bakhtiari, Bradly G Wouters, Giuseppe V Masucci, Emilia K Andersson, Eva Zavadova, Michal Vocka, Jan Spacek, Lubos Petruzelka, Bohuslav Konopasek, Pavel Dundr, Helena Skalova, Kristyna Nemejcova, Gerardo Botti, Fabiana Tatangelo, Paolo Delrio, Gennaro Ciliberto, Michele Maio, Luigi Laghi, Fabio Grizzi, Tessa Fredriksen, Bénédicte Buttard, Lucie Lafontaine, Pauline Maby, Amine Majdi, Assia Hijazi, Carine El Sissy, Amos Kirilovsky, Anne Berger, Christine Lagorce, Christopher Paustian, Carmen Ballesteros-Merino, Jeroen Dijkstra, Carlijn van de Water, Shannon van Lent-van Vliet, Nikki Knijn, Ana-Maria Mușină, Dragos-Viorel Scripcariu, Boryana Popivanova, Mingli Xu, Tomonobu Fujita, Shoichi Hazama, Nobuaki Suzuki, Hiroaki Nagano, Kiyotaka Okuno, Toshihiko Torigoe, Noriyuki Sato, Tomohisa Furuhata, Ichiro Takemasa, Prabhu Patel, Hemangini H Vora, Birva Shah, Jayendrakumar B Patel, Kruti N Rajvik, Shashank J Pandya, Shilin N Shukla, Yili Wang, Guanjun Zhang, Yutaka Kawakami, Francesco M Marincola, Paolo A Ascierto, Bernard A Fox, Franck Pagès, and Jérôme Galon
Peripheral and tissue persistence of agenT-797, an allogeneic iNKT cell-based cell therapy for the treatment of cancer, J Moon, Rachel Sanborn, Dave Hoon, and See full list of authors in comments
A phase 1/1b study of the tumor-activated IL-2 prodrug WTX-124 alone or in combination with pembrolizumab in patients with immunotherapy-sensitive locally advanced or metastatic solid tumors, JC Moser, Brendan Curti, and See full list of authors in comments
PD-1 expression on tumor-infiltrating T-lymphocytes as determinant of the head and neck cancer tumor immune microenvironment rather than anatomical site, T Muijlwijk, Bernard Fox, and See full list of authors in comments
Localized Contrastive and Attention Based Multiple Instance Learning for Automatic Staging of Histopathology Images., N Naik, Carlo Bifulco, Brian Piening, and See full list of authors in comments
Medical Management and Device-Based Therapies in Chronic Heart Failure, AH Nguyen, Jacob Abraham, and See full list of authors in comments
Medical Management and Device-Based Therapies in Chronic Heart Failure, AH Nguyen, M Hurwitz, Jacob Abraham, V Blumer, MC Flanagan, AR Garan, M Kanwar, R Kataria, JLW Kennedy, A Kochar, J Hernandez-Montfort, M Pahuja, P Shah, MW Sherwood, BN Tehrani, S Vallabhajosyula, NK Kapur, and SS Sinha
Reconstructing the Mandible: Jaw-In-A-Day: Where We Were, Where We Are, and the Future., David Omole, Baber Khatib, Ashish A Patel, Allen Cheng, Andrew Salama, Lawrence E Brecht, and David L Hirsch
Molecular features associated with long survival on tebentafusp in previously untreated metastatic uveal melanoma in a phase 3 trial, M Orloff, Brendan Curti, and See full list of authors in comments
Novel Directions of ADCs in Breast Cancer. Binaytara Foundation Highlights from SABCS 2022; 2023 January 20; Seattle, WA., David B Page
A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer., David B Page, Joanna Pucilowska, Brie Chun, Isaac Kim, Katherine Sanchez, Nicole Moxon, Staci Mellinger, Yaping Wu, Yoshinobu Koguchi, Valerie Conrad, William L Redmond, Maritza Martel, Zhaoyu Sun, Mary B Campbell, Alison Conlin, Anupama Acheson, Reva Basho, Philomena McAndrew, Mary El-Masry, Dorothy Park, Laura Bennetts, Robert S Seitz, Tyler J Nielsen, Kimberly McGregor, Venkatesh Rajamanickam, Brady Bernard, Walter J Urba, and Heather L McArthur
A phase II study of nivolumab plus ipilimumab and androgen receptor antagonist bicalutamide to stimulate thymic T cell generation in HER2-negative metastatic breast cancer, David Page, Allison Conlin, Sasha Stanton, Walter Urba, Will Redmond, and See full list of authors in comments
Association of pathologic complete response with the 27-gene IO score and week 3 IOpath response following neoadjuvant pembrolizumab +/- intralymphatic cytokines in the neoIRX trial, David Page, Will Redmond, Allison Conlin, S Stanton, and See full list of authors in comments
Impact of Sex on Cardiogenic Shock Outcomes: A Cardiogenic Shock Working Group Report, M Pahuja, Jacob Abraham, and See full list of authors in comments
Fellow's Course: Finding your Dream Job, MJ Paisley
Multi-institutional validation of a radiomics-based artificial intelligence method for predicting response to PD-1/PD-L1 immune checkpoint inhibitor (ICI) therapy in stage IV NSCLC, RB Parikh, Brendan Curti, and See full list of authors in comments
Phase 1/2 study of the bispecific 4–1BB and PD-L1 antibody INBRX-105 alone and in combination with pembrolizumab in select solid tumors, JC Park, Rachel Sanborn, and See full list of authors in comments
Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study., Keunchil Park, Joshua K Sabari, Eric B Haura, Catherine A Shu, Alexander Spira, Ravi Salgia, Karen L Reckamp, Rachel E Sanborn, Ramaswamy Govindan, Joshua M Bauml, Joshua C Curtin, John Xie, Amy Roshak, Patricia Lorenzini, Dawn Millington, Meena Thayu, Roland E Knoblauch, and Byoung Chul Cho
On-site treatment of avalanche victims: Scoping review and 2023 recommendations of the international commission for mountain emergency medicine (ICAR MedCom)., M Pasquier, G Strapazzon, A Kottmann, P Paal, K Zafren, K Oshiro, C Artoni, C Van Tilburg, A Sheets, J Ellerton, K McLaughlin, L Gordon, R W Martin, M Jacob, M Musi, M Blancher, C Jaques, and H Brugger
Screening for occult cancer after unprovoked venous thromboembolism: Assessing the current literature and future directions., Sarah S Patel, Derrick Tao, Hannah S McMurry, and Joseph J Shatzel
Multi-parametric assessment of the immune response to a trio immunotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma, C Paustian, Matthew Taylor, Will Redmond, B Bernard, RB Bell, Carlo Bifulco, Brian Piening, Walter Urba, Bernard Fox, Rom Leidner, and See full list of authors in comments
Arterial, Venous and Lymphedema Management, Alejandro Perez
Lower Extremity Edema: Diagnosis and Management, Alejandro Perez
Tips For Readers: Mesenteric and Renal Arteries, Alejandro Perez
Brief training in ultrasound equips novice clinicians to accurately and reliably measure jugular venous pressure in obese patients., Nicholas Pettit, Benjamin Pedroja, Hsin-Fang Li, and Michael G Sutcliffe
Great mimicker: definite isolated cardiac sarcoidosis masquerading as hypertrophic cardiomyopathy., Tuan Pham, Jacob Abraham, and Farooq H Sheikh
NICUs in the US: levels of acuity, number of beds, and relationships to population factors., Roberta Pineda, Kathryn C R Knudsen, Courtney C Breault, Elizabeth E Rogers, Wendy J Mack, and Alicia Fernandez-Fernandez
Abstract 6764: Multi-parametric comparison of scRNA-seq with CITE-seq and ultrahigh-plex spatial phenotyping of proteins in FFPE head and neck tumor biopsies: An opportunity to generate uniquely comprehensive multi-omic single cell datasets to investigate the tumor microenvironment, Aditya Pratapa, Brady Bernard, Brian D. Piening, Rom Leidner, Bernard A Fox, and See all authors in comments
The role of dendritic cells in radiation-induced immune responses., A Preet Kaur, A Alice, MR Crittenden, and MJ Gough
Toward structuring real-world data: Deep learning for extracting oncology information from clinical text with patient-level supervision., Sam Preston, Mu Wei, Rajesh Rao, Robert Tinn, Naoto Usuyama, Michael Lucas, Yu Gu, Roshanthi Weerasinghe, Soohee Lee, Brian D. Piening, Paul Tittel, Naveen Valluri, Tristan Naumann, Carlo Bifulco, and Hoifung Poon
A Network Landscape of HPVOPC Reveals Methylation Alterations as Significant Drivers of Gene Expression via an Immune-Mediated GPCR Signal., Jesse R Qualliotine, Takuya Nakagawa, Sara Brin Rosenthal, Sayed Sadat, Carmen Ballesteros-Merino, Guorong Xu, Adam Mark, Art Nasamran, J Silvio Gutkind, Kathleen M Fisch, Theresa Guo, Bernard A Fox, Zubair Khan, Alfredo A Molinolo, and Joseph A Califano
Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial., Tulika Ranjan, Soma Sengupta, Michael J Glantz, Richard M Green, Alexander Yu, Dawit Aregawi, Rekha Chaudhary, Ricky Chen, Mario Zuccarello, Christine Lu-Emerson, Hugh D Moulding, Neil Belman, Jon Glass, Aaron Mammoser, Mark Anderson, Jagan Valluri, Nicholas Marko, Jason Schroeder, Steven Jubelirer, Frances Chow, Pier Paolo Claudio, Anthony M Alberico, Seth T Lirette, Krista L Denning, and Candace M Howard
Challenges and opportunities in the development of combination immunotherapy with OX40 agonists., William L Redmond
Enhancement of anti-tumor efficacy of immune checkpoint blockade by alpha-TEA., William L. Redmond, Melissa Kasiewicz, and Emmanuel T Akporiaye
Multimodal single-cell analysis of human TILs across multiple tumor types reveals heterogeneity and potential opportunities for personalized immunotherapy, Will Redmond and See all authors in comments
Advances in Cancer Immunotherapy, WL Redmond
Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry., Charles J Robbins, Aileen I Fernandez, Gang Han, Serena Wong, Malini Harigopal, Mirna Podoll, Kamaljeet Singh, Amy Ly, M Gabriela Kuba, Hannah Wen, Mary Ann Sanders, Jane Brock, Shi Wei, Oluwole Fadare, Krisztina Hanley, Julie Jorns, Olivia L Snir, Esther Yoon, Kim Rabe, T Rinda Soong, Emily S Reisenbichler, and David L Rimm
First-Time Prescribing of GLP-1 Receptor Agonists from 2018-2023: A Descriptive Analysis, Patricia Rodriguez, Ty Gluckman, Nicholas L. Stucky, and See full list of authors in comments
Real-World Effectiveness of SGLT2 Inhibitors Vs Metformin As First-Line Therapy in Type 2 Diabetes, Patricia Rodriguez, Samuel Gratzl, Ryan Lee, Sarah Gilson, Peter Smits, Nicholas L Stucky, and Tyler J Gluckman
Real-World Effectiveness of SGLT2 Inhibitors Vs Metformin As First-Line Therapy in Type 2 Diabetes, PJ Rodriguez, Tyler Gluckman, and See full list of authors in comments
Comparative Effectiveness of Semaglutide and Tirzepatide for Weight Loss in Adults with Overweight and Obesity in the US: A Real-World Evidence Study, PJ Rodriguez, BM Goodwin Cartwright, S Gratzl, R Brar, C Baker, Tyler J Gluckman, and NL Stucky
First-Time Prescribing of GLP-1 Receptor Agonists from 2018-2023: A Descriptive Analysis, PJ Rodriguez, S Gratzl, BM Goodwin Cartwright, R Brar, Tyler J Gluckman, and NL Stucky
